A common mutation in the KRAS gene is associated with improved overall survival in pancreatic ductal adenocarcinoma (PDAC) ...
A common mutation in the KRAS gene is associated with improved overall survival in pancreatic ductal adenocarcinoma (PDAC) compared with other variants, in part because the mutation appears to lead to ...
A common mutation in the KRAS gene is associated with improved overall survival in pancreatic ductal adenocarcinoma (PDAC) ...
Despite higher levels of mRNA encoding SG proteins during pancreatic tumorigenesis, this study finds no SG formation in ...
The following is a summary of “Association of mutation profiles with metastasis in patients with non-small cell lung cancer,” ...
A common mutation in the KRAS gene is associated with improved overall survival in pancreatic ductal adenocarcinoma (PDAC) compared with other ...
Northwestern Medicine investigators have discovered that a novel combination therapy promotes cancer cell death and tumor ...
The FDA is looking at four events for the remainder of October, one of which is an advisory committee meeting for a dual SGLT ...
Silexion Therapeutics Corp. (NASDAQ: SLXN) ("Silexion" or the "Company"), a clinical-stage biotech developing RNA ...